Device Trial Radar · NCT04546438
Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis
Last checked: Nov 20, 2026Latest source record: Dec 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Sep 4, 2020
Primary completion
Dec 1, 2023
Study completion Dec 1, 2023
Sponsor
- Lead sponsor
- Region ÖstergötlandAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 14, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary localized hyperhidrosis is a dermatological disorder that involves excessive sweat production without an underlying cause. The disease usually affects the axillae but can also involve palms, soles of the feet or face and causes major problems in many social situations with a negative impact on quality of life and mental health. In this study, the investigators want to investigate the effect of microwave therapy (MiraDry®) on self-rated sweating, quality of life and anxiety in participants with severe axillary hyperhidrosis. The study also aims to evaluate the safety (side effects) of the method and long term effects over 1 year of follow upp.
Conditions
- Axillary Hyperhidrosis
Interventions
miraDry®Device
MiraDry is a noninvasive method that uses microwave technology to destroy sweat glands. In this study we evaluate a higher energy level with a newer generation device, in respect with side effects and number of treatments (one or two interventions).
Primary outcomes
What the sponsor says the trial is designed to measure.
- The effectiveness of miraDry treatmentTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Vrinnevisjukhuset
Norrköping, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.